Aimin Jiang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 25

Top Topics

Rheumatoid Arthritis

Cancer Stem Cells

Machine Learning

Top Venues

Oxidative medicine and cellular longevity

Journal of cellular and molecular medicine

Cancer biology & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Hualei Dai, Ying Liu, Meng Zhu, Siming Tao, Chengcheng Hu, Peng Luo, Aimin Jiang, Guimin Zhang
Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers. Journal of cellular and molecular medicine 28 (16) (2024)
Hualei Dai, Ying Liu, Meng Zhu, Siming Tao, Chengcheng Hu, Peng Luo, Aimin Jiang, Guimin Zhang
Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers. Journal of cellular and molecular medicine 28 (16) (2024)
Hualei Dai, Ying Liu, Meng Zhu, Siming Tao, Chengcheng Hu, Peng Luo, Aimin Jiang, Guimin Zhang
Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers. Journal of cellular and molecular medicine 28 (16) (2024)
Ying Liu, Lin Qi, Bicheng Ye, Anbang Wang, Juan Lu, Le Qu, Peng Luo, Linhui Wang, Aimin Jiang
MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer biology & therapy 25 (1) (2024)
Bicheng Ye, Ge Hongting, Wen Zhuang, Cheng Chen, Shulin Yi, Xinyan Tang, Aimin Jiang, Yating Zhong
Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. Journal of cellular and molecular medicine 28 (14) (2024)
Fucun Liu, Juelan Ye, Shouli Wang, Yang Li, Yuhang Yang, Jianru Xiao, Aimin Jiang, Xuhua Lu, Yunli Zhu
Identification and Verification of Novel Biomarkers Involving Rheumatoid Arthritis with Multimachine Learning Algorithms: An In Silicon and In Vivo Study. Mediators of inflammation 2024 (2024)
Ying Liu, Lin Qi, Bicheng Ye, Anbang Wang, Juan Lu, Le Qu, Peng Luo, Linhui Wang, Aimin Jiang
MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer biology & therapy 25 (1) (2024)
Fucun Liu, Juelan Ye, Shouli Wang, Yang Li, Yuhang Yang, Jianru Xiao, Aimin Jiang, Xuhua Lu, Yunli Zhu
Identification and Verification of Novel Biomarkers Involving Rheumatoid Arthritis with Multimachine Learning Algorithms: An In Silicon and In Vivo Study. Mediators of inflammation 2024 (2024)
Ying Liu, Lin Qi, Bicheng Ye, Anbang Wang, Juan Lu, Le Qu, Peng Luo, Linhui Wang, Aimin Jiang
MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer biology & therapy 25 (1) (2024)
Ying Liu, Lin Qi, Bicheng Ye, Anbang Wang, Juan Lu, Le Qu, Peng Luo, Linhui Wang, Aimin Jiang
MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level. Cancer biology & therapy 25 (1) (2024)
Bicheng Ye, Ge Hongting, Wen Zhuang, Cheng Chen, Shulin Yi, Xinyan Tang, Aimin Jiang, Yating Zhong
Deciphering lung adenocarcinoma prognosis and immunotherapy response through an AI-driven stemness-related gene signature. Journal of cellular and molecular medicine 28 (14) (2024)
Fucun Liu, Juelan Ye, Shouli Wang, Yang Li, Yuhang Yang, Jianru Xiao, Aimin Jiang, Xuhua Lu, Yunli Zhu
Identification and Verification of Novel Biomarkers Involving Rheumatoid Arthritis with Multimachine Learning Algorithms: An In Silicon and In Vivo Study. Mediators of inflammation 2024 (2024)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 12 (3) (2023)
Jia-Lin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. iMeta 2 (4) (2023)
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 12 (3) (2023)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 12 (3) (2023)
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 12 (3) (2023)
Aimin Jiang, Chen Cai, Yiren Yang, Yankang Cui, Wenqiang Liu, Qingyang Pang, Zhenjie Wu, Bing Liu, Le Qu, Peng Luo, Anbang Wang, Linhui Wang
Deciphering the Role of Melatonin-Related Signatures in Tumor Immunity and the Prognosis of Clear Cell Renal Cell Carcinoma. Oxidative medicine and cellular longevity 2023 (2023)
Aimin Jiang, Juelan Ye, Ye Zhou, Baohua Zhu, Juan Lu, Silun Ge, Le Qu, Jianru Xiao, Linhui Wang, Chen Cai
Copper Death Inducer, FDX1, as a Prognostic Biomarker Reshaping Tumor Immunity in Clear Cell Renal Cell Carcinoma. Cells 12 (3) (2023)
Jia-Lin Meng, Aimin Jiang, Xiaofan Lu, Di Gu, Qintao Ge, Suwen Bai, Yundong Zhou, Jun Zhou, Zongyao Hao, Fangrong Yan, Linhui Wang, Haitao Wang, Juan Du, Chaozhao Liang
Multiomics characterization and verification of clear cell renal cell carcinoma molecular subtypes to guide precise chemotherapy and immunotherapy. iMeta 2 (4) (2023)
Aimin Jiang, Yewei Bao, Anbang Wang, Wenliang Gong, Xinxin Gan, Jie Wang, Yi Bao, Zhenjie Wu, Bing Liu, Juan Lu, Linhui Wang
Establishment of a Prognostic Prediction and Drug Selection Model for Patients with Clear Cell Renal Cell Carcinoma by Multiomics Data Analysis. Oxidative medicine and cellular longevity 2022 (2022)
Aimin Jiang, Ye Zhou, Wenliang Gong, Xin Pan, Xinxin Gan, Zhenjie Wu, Bing Liu, Le Qu, Linhui Wang
CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types. Oxidative medicine and cellular longevity 2022 (2022)
Anbang Wang, Aimin Jiang, Xinxin Gan, Zheng Wang, Jinming Huang, Kai Dong, Bing Liu, Linhui Wang, Ming Chen
EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR. BioMed research international 2020 (2020)